INBS Intelligent Bio Solutions Inc. - Common Stock
NASDAQ · Health Care · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 19, 2026
$1,66
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$0,64minimo 52 sett.
$24,90massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$5M
P/E (TTM)
-0.2
EPS (TTM)
$-8.44
Ricavi (TTM)
$4M
i tuoi badge
Intervallo 52 sett.
$1–$25
Rating Analisti
STRONG BUY
Prezzo Obiettivo
$12
P/E
-0.2
ROE
-292.3%
Margine di Profitto Netto
-294.9%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
INBS Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$1.66
Capitalizzazione di Mercato (MRQ)
$5M
P/E (TTM)
-0.2
EPS (TTM)
$-8.44
Ricavi (TTM)
$4M
ROE (TTM)
-292.3%
Intervallo 52 sett.
$1–$25
INBS Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 16 Dicembre 2025 | 1-for-10 | Inverso |
| 29 Gennaio 2024 | 1-for-12 | Inverso |
| 10 Febbraio 2023 | 1-for-20 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$4M2020-06-30 → 2026-06-30
EPS$-8.442022-06-30 → 2026-06-30
Flusso di cassa libero$-12M2025-06-30 → 2026-06-30
Margine netto-294.9%2023-06-30 → 2026-06-30
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | INBS | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | -0.2media 5 anni ≈-3.1 | ≈-3.1 | · | · | |
| P/S (TTM) | 1.1media 5 anni ≈22.5 | ≈22.5 | 3.9 | Sottovalutato | |
| P/B (MRQ) | 0.9media 5 anni ≈8.6 | ≈8.6 | 1.2 | Valore equo | |
| Prezzo / FCF (TTM) | -0.4 | · | · | · | |
| Prezzo / Flusso di cassa (TTM) | -0.4media 5 anni ≈-4.1 | ≈-4.1 | · | · | |
| Prezzo / Valore contabile tangibile (MRQ) | 1.8media 5 anni ≈120.4 | ≈120.4 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | INBS | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine lordo (TTM) | 48.6%media 5 anni ≈38.5% | ≈38.5% | · | · | |
| Margine Operativo (TTM) | -299.1%media 5 anni ≈-550.0% | ≈-550.0% | -2015.8% | Di prim'ordine | |
| EBITDA Margin (Margine EBITDA) | -299.1%media 5 anni ≈-517.8% | ≈-517.8% | -2015.8% | Di prim'ordine | |
| Margine di Profitto Netto (TTM) | -294.9%media 5 anni ≈-495.7% | ≈-495.7% | -2038.7% | Di prim'ordine | |
| ROA (TTM) | -123.1%media 5 anni ≈-104.2% | ≈-104.2% | -114.7% | In linea | |
| ROE (TTM) | -292.3%media 5 anni ≈-227.6% | ≈-227.6% | -160.6% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | INBS | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 1.4media 5 anni ≈1.0 | ≈1.0 | 3.2 | Bassa liquidità | |
| Quick Ratio | 1.0media 5 anni ≈0.5 | ≈0.5 | 1.8 | Bassa liquidità |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | INBS | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 38.1%media 5 anni ≈58.7% | ≈58.7% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 49.7%media 5 anni ≈61.3% | ≈61.3% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 16.3% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | INBS | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.4media 5 anni ≈0.3 | ≈0.3 | 0.1 | Di prim'ordine | |
| Inventory Turnover (Rotazione delle scorte) | 4.1media 5 anni ≈2.9 | ≈2.9 | 1.7 | Di prim'ordine | |
| Receivables Turnover (Rotazione dei crediti) | 5.8media 5 anni ≈6.8 | ≈6.8 | 5.9 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$71.4K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-20.4%
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 31 Dicembre 2026 | Ago 19, 2026 | $-0.90 | $-1.61 | 44.2% |
| 30 Giugno 2026 | $-0.90 | $-1.61 | 44.2% | |
| 30 Settembre 2024 | $-7.00 | $-5.41 | -29.5% | |
| 30 Giugno 2024 | $-13.40 | $-5.20 | -157.6% | |
| 31 Marzo 2024 | $-14.30 | $-8.87 | -61.1% | |
| 31 Dicembre 2023 | $-20.70 | $-33.05 | 37.4% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $3M | $3M | $1M | · | $2M | $188.7K | |
| Cost of Revenue | $2M | $2M | $2M | $930.2K | · | · | · | |
| Gross Profit | $2M | $1M | $1M | $326.7K | · | · | · | |
| SG&A Expense | $11M | $9M | $9M | $8M | $5M | $3M | $2M | |
| Operating Expenses | $15M | $13M | $12M | $14M | $9M | $8M | $3M | |
| Operating Income | $-13M | $-11M | $-10M | $-13M | $-8M | $-6M | $-3M | |
| Interest Income | $110.3K | $101.5K | $84.8K | · | · | · | · | |
| Other Non-op | $139.4K | $74.3K | $92.2K | $2M | $2.9K | $-1M | $-336.0K | |
| Pretax Income | · | · | · | · | · | $-7M | $-3M | |
| Net Income | $-12M | $-11M | $-10M | $-11M | $-8M | $-7M | $-3M | |
| EPS (Basic) | $-8.44 | $-20.04 | $-6.38 | $-127.00 | $-11.33 | $-0.68 | · | |
| EPS (Diluted) | $-8.44 | $-20.04 | $-6.38 | $-127.00 | $-11.33 | · | · | |
| Shares (Basic) | 1,472,744 | 527,364 | 1,592,746 | 83,717 | 733,263 | 10,414,886 | · | |
| Shares (Diluted) | 1,472,744 | 527,364 | 1,592,746 | 83,717 | 733,263 | · | · | |
| EBITDA | $-13M | $-10M | · | $-12M | · | · | · |
Stato Patrimoniale
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $1M | $6M | $2M | $8M | $13M | $427.3K | |
| Receivables | $848.5K | $594.6K | $429.7K | $293.9K | · | · | · | |
| Inventory | $418.6K | $635.2K | $777.5K | $979.9K | · | · | · | |
| Prepaid Expense | $1M | $827.0K | $363.1K | $360.0K | $116.5K | $2M | $29.5K | |
| Other Current Assets | $1M | $827.0K | $497.6K | $552.8K | $746.8K | $3M | $49.1K | |
| Current Assets | $7M | $4M | $9M | $4M | $11M | $18M | $2M | |
| PP&E (Net) | $294.4K | $251.3K | $565.9K | $690.2K | $391.4K | · | · | |
| PP&E (Gross) | $449.1K | $339.5K | $626.6K | $723.9K | $391.4K | · | · | |
| Accum. Depreciation | $154.7K | $88.2K | $60.8K | $33.8K | · | · | · | |
| Intangibles | $3M | $4M | $4M | $5M | · | · | · | |
| Other Non-current Assets | · | · | · | · | · | $504.0K | · | |
| Total Assets | $12M | $8M | $14M | $10M | $12M | $22M | $2M | |
| Accounts Payable | $712.4K | $897.3K | $2M | $3M | $2M | $1M | $787.5K | |
| Accrued Liabilities | · | $1M | $607.2K | $777.1K | $909.2K | · | · | |
| Short-term Debt | · | $197.1K | $515.3K | $353.2K | · | · | · | |
| Current Liabilities | $5M | $5M | $5M | $6M | $5M | $4M | $8M | |
| Capital Leases | $2M | · | $81.3K | $356.2K | · | · | · | |
| Total Liabilities | $7M | $5M | $6M | $7M | $6M | $7M | $8M | |
| Total Debt | · | $197.1K | · | $353.2K | · | · | · | |
| Common Stock | $29.1K | $7.3K | $34.6K | $1.9K | $7.4K | $135.8K | $86.3K | |
| Paid-in Capital | $81M | $66M | $61M | $46M | $39M | $38M | $11M | |
| Retained Earnings | $-75M | $-63M | $-52M | $-42M | $-31M | $-23M | $-16M | |
| Treasury Stock | $1 | $1 | $1 | $1 | · | · | · | |
| AOCI | $-546.2K | $-327.9K | $-712.6K | $-575.5K | $-788.1K | $-661.3K | $-364.0K | |
| Stockholders' Equity | $6M | $3M | $8M | $4M | $7M | $15M | $-5M | |
| Liabilities + Equity | $12M | $8M | $14M | $10M | $12M | $22M | $2M | |
| Shares Outstanding | 2,905,603 | 732,327 | 3,456,000 | 194,200 | 744,496 | 13,582,122 | 8,630,000 |
Flusso di cassa
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $970.1K | $974.4K | $814.5K | · | · | · | |
| Stock-based Comp | $195.2K | $238.0K | $230.5K | $260.0K | · | · | · | |
| Amort. of Intangibles | $1M | $949.3K | $947.4K | $805.8K | $0 | · | · | |
| Other Non-cash | · | $-316.7K | · | $2M | · | · | · | |
| Operating Cash Flow | $-12M | $-10M | $-10M | $-7M | $-3M | $-11M | $-498.6K | |
| CapEx | $125.7K | $231.8K | $221.4K | · | · | · | · | |
| Investing Cash Flow | $-85.6K | $-231.8K | $-221.4K | $-694.1K | $-880.2K | · | $-14.0K | |
| Stock Issued | · | · | · | · | · | $508.3K | · | |
| Financing Cash Flow | $15M | $5M | $15M | $1M | · | $23M | $733.9K | |
| Net Change in Cash | $3M | $-5M | $5M | $-7M | $-4M | $12M | $229.3K | |
| Free Cash Flow | $-12M | $-10M | · | · | · | · | · |
Redditività
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 48.6% | 40.8% | · | 26.0% | · | · | · | |
| Operating Margin | -299.1% | -348.7% | · | -1002.1% | · | · | · | |
| Net Margin | -294.9% | -346.2% | · | -845.9% | · | · | · | |
| EBITDA Margin | -299.1% | -316.9% | · | -937.3% | · | · | · | |
| ROA | -123.1% | -96.0% | · | -93.6% | · | · | · | |
| ROE | -292.2% | -186.6% | · | -204.0% | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 0.8 | · | 0.7 | · | · | · | |
| Quick Ratio | 1.0 | 0.3 | · | 0.3 | · | · | · | |
| Debt / Equity | · | 0.1 | · | 0.1 | · | · | · |
Efficienza
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.3 | · | 0.1 | · | · | · | |
| Inventory Turnover | 4.1 | 2.6 | · | 1.9 | · | · | · | |
| Receivables Turnover | 5.8 | 6.0 | · | 8.6 | · | · | · |
Per Azione
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.90 | $0.41 | · | $1.63 | · | · | · | |
| Revenue / Share | $2.86 | $0.58 | · | $1.25 | · | · | · | |
| Cash Flow / Share | $-8.10 | $-1.83 | · | $-7.34 | · | · | · | |
| Cash / Share | $1.37 | $0.14 | · | $0.66 | · | · | · | |
| EPS (TTM) | $-8.44 | $-2.00 | $-6.38 | $-127.00 | $-11.33 | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 38.1% | -1.9% | 147.6% | 187.5% | -77.9% | 949.3% | · | |
| Revenue CAGR 3Y | 49.7% | 91.1% | 16.3% | 88.1% | · | · | · | |
| Revenue CAGR 5Y | 16.3% | 74.5% | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $3M | $3M | $1M | $371.2K | $2M | · | |
| Net Income TTM | $-12M | $-11M | $-10M | $-11M | $-8M | $-7M | · | |
| Market Cap | $7M | $13M | · | $78M | · | · | · | |
| Enterprise Value | · | $12M | · | $77M | · | · | · | |
| P/E | -0.3 | -0.9 | -0.3 | -0.3 | -14.0 | · | · | |
| P/S | 1.6 | 4.1 | · | 61.9 | · | · | · | |
| P/B | 1.2 | 4.2 | · | 20.5 | · | · | · | |
| P / Tangible Book | 2.5 | · | 1.7 | · | 357.1 | 852.9 | · | |
| P / Cash Flow | -0.6 | -1.3 | · | -10.5 | · | · | · | |
| P / FCF | -0.6 | -1.3 | · | · | · | · | · | |
| EV / EBITDA | · | -1.2 | · | -6.5 | · | · | · | |
| EV / FCF | · | -1.2 | · | · | · | · | · | |
| EV / Revenue | · | 3.9 | · | 60.9 | · | · | · | |
| Earnings Yield | -367.8% | -116.3% | -332.3% | -380.7% | -7.1% | · | · |
Conto Economico
| Metrica | Tendenza | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $1M | $896.8K | $1M | $843.9K | $728.9K | $607.5K | $872.3K | $380.9K | $907.6K | $917.3K | $906.0K | $131.8K | $457.1K | $356.7K | · | |
| Cost of Revenue | $609.2K | $525.4K | $437.0K | $593.5K | $508.3K | $387.5K | $384.4K | $525.5K | $-87.7K | $645.3K | $564.8K | $563.8K | $393.6K | $424.0K | $112.6K | · | |
| Gross Profit | $536.6K | $535.4K | $459.7K | $518.3K | $335.6K | $341.4K | $223.1K | $346.8K | $815.6K | $178.5K | $199.2K | $232.3K | $49.6K | $33.0K | $244.0K | · | |
| SG&A Expense | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Operating Expenses | $5M | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $4M | $3M | $2M | $3M | $3M | $7M | $3M | $2M | |
| Operating Income | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-3M | $-3M | $-2M | $-3M | $-3M | $-7M | $-2M | $-1M | |
| Interest Income | $47.0K | $49.4K | $5.3K | $8.5K | $9.1K | $17.7K | $21.9K | $52.8K | $70.5K | $10.6K | $3.5K | $139 | · | · | · | · | |
| Other Non-op | $108.2K | $77.5K | $-50.9K | $4.6K | $26.5K | $9.7K | $7.7K | $30.5K | $16.4K | $-33.0K | $15.0K | $93.9K | $31.1K | $191.4K | $2M | $4.3K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | · | · | $-6M | · | · | |
| Net Income | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-3M | $-3M | $-2M | $-2M | $-3M | $-6M | $-420.6K | $-1M | |
| EPS (Basic) | $-3.47 | $-1.80 | $-2.82 | $-0.35 | $-9.97 | $-4.41 | $-4.96 | $-0.70 | $9.60 | $-1.43 | $-2.07 | $-12.48 | $-51.15 | $-68.67 | $-5.56 | $-1.62 | |
| EPS (Diluted) | $-3.47 | $-1.80 | $-2.82 | $-0.35 | $-9.97 | $-4.41 | $-4.96 | $-0.70 | $9.60 | $-1.43 | $-2.07 | $-12.48 | $-51.15 | $-68.67 | $-5.56 | $-1.62 | |
| Shares (Basic) | · | 1,594,496 | 950,829 | 8,546,934 | · | 577,191 | 453,582 | 3,811,090 | · | 2,079,864 | 949,660 | 194,200 | · | 92,389 | 75,690 | 14,889,904 | |
| Shares (Diluted) | · | 1,594,496 | 950,829 | 8,546,934 | · | 577,191 | 453,582 | 3,811,090 | · | 2,079,864 | 949,660 | 194,200 | · | 92,389 | 75,690 | 744,495 | |
| EBITDA | · | $-3M | $-3M | $-3M | · | $-3M | $-2M | $-2M | · | $-3M | $-2M | $-2M | · | $-7M | $-2M | $-1M |
Stato Patrimoniale
| Metrica | Tendenza | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $7M | $740.4K | $2M | $1M | $3M | $2M | $4M | $6M | $9M | $1M | $186.4K | $2M | $2M | $3M | $6M | |
| Receivables | $848.5K | $878.4K | $456.7K | $717.8K | $594.6K | $511.0K | $266.1K | $578.6K | $429.7K | $431.6K | $262.8K | $567.5K | $293.9K | $296.0K | $278.3K | · | |
| Inventory | $418.6K | $597.5K | $590.2K | $628.2K | $635.2K | $683.5K | $701.3K | $738.8K | $777.5K | $877.9K | $942.0K | $965.1K | $979.9K | $736.2K | $671.0K | · | |
| Prepaid Expense | $1M | $843.1K | · | · | $827.0K | · | · | · | $363.1K | · | · | · | $360.0K | $390.5K | $329.8K | $41.5K | |
| Other Current Assets | $1M | · | $480.1K | $488.2K | $827.0K | $585.5K | $348.7K | $396.2K | $497.6K | $481.0K | $331.6K | $413.3K | $552.8K | $531.8K | $521.9K | $148.9K | |
| Current Assets | $7M | $10M | $12M | $4M | $4M | $5M | $4M | $6M | $9M | $12M | $3M | $3M | $4M | $4M | $6M | $8M | |
| PP&E (Net) | $294.4K | $312.3K | $321.7K | $271.7K | $251.3K | $546.5K | $537.2K | $586.1K | $565.9K | $559.5K | $591.3K | $664.9K | $690.2K | $478.1K | $484.3K | $416.0K | |
| PP&E (Gross) | $449.1K | · | · | · | $339.5K | · | · | · | $626.6K | · | · | · | $723.9K | $494.0K | $493.8K | · | |
| Accum. Depreciation | $154.7K | · | · | · | $88.2K | · | · | · | $60.8K | · | · | · | $33.8K | $15.9K | $9.5K | $416.0K | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | · | |
| Intangibles | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $504.9K | |
| Total Assets | $12M | $15M | $18M | $10M | $8M | $10M | $9M | $12M | $14M | $17M | $9M | $9M | $10M | $11M | $18M | $10M | |
| Accounts Payable | $712.4K | $4M | $4M | $4M | $897.3K | $1M | $1M | $2M | $2M | $2M | $2M | $4M | $3M | $2M | $2M | $1M | |
| Accrued Liabilities | · | · | · | · | $1M | · | · | · | $607.2K | · | · | · | $777.1K | $385.7K | $309.5K | · | |
| Short-term Debt | · | · | $13.0K | $139.8K | $197.1K | $356.2K | $405.5K | $499.6K | $515.3K | $368.5K | $370.5K | $341.8K | $353.2K | $335.5K | $326.0K | · | |
| Current Liabilities | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $6M | $5M | $6M | $5M | $7M | $6M | $4M | $5M | $2M | |
| Capital Leases | $2M | $1M | $2M | $1M | · | $3.7K | $14.5K | $28.1K | $81.3K | $154.2K | $228.7K | $284.0K | $356.2K | · | · | · | |
| Total Liabilities | $7M | $6M | $7M | $7M | $5M | $5M | $4M | $6M | $6M | $6M | $6M | $7M | $7M | $5M | $8M | $5M | |
| Total Debt | · | · | $13.0K | $139.8K | · | $356.2K | $405.5K | $499.6K | · | $368.5K | $370.5K | $341.8K | · | $335.5K | $326.0K | · | |
| Common Stock | $29.1K | $20.0K | $12.4K | $91.0K | $7.3K | $67.9K | $48.1K | $43.8K | $34.6K | $29.1K | $14.8K | $23.3K | $1.9K | $16.9K | $9.2K | $148.9K | |
| Paid-in Capital | $81M | $80M | $80M | $69M | $66M | $65M | $62M | $61M | $61M | $61M | $50M | $46M | $46M | $46M | $44M | $38M | |
| Retained Earnings | $-75M | $-71M | $-68M | $-66M | $-63M | $-59M | $-57M | $-55M | $-52M | $-49M | $-46M | $-44M | $-42M | $-39M | $-33M | $-32M | |
| Treasury Stock | $1 | $1 | $1 | $1 | $1 | $1 | $1 | $1 | $1 | $1 | $1 | $14 | $1 | $14 | $14 | · | |
| AOCI | $-546.2K | $-499.7K | $-266.1K | $-279.2K | $-327.9K | $-523.4K | $-639.4K | $-496.3K | $-712.6K | $-662.4K | $-518.4K | $-593.5K | $-575.5K | $-639.9K | $-562.1K | $-923.7K | |
| Stockholders' Equity | $6M | $9M | $11M | $4M | $3M | $5M | $4M | $6M | $8M | $11M | $3M | $1M | $4M | $6M | $10M | $5M | |
| Liabilities + Equity | $12M | $15M | $18M | $10M | $8M | $10M | $9M | $12M | $14M | $17M | $9M | $9M | $10M | $11M | $18M | $10M | |
| Shares Outstanding | 2,905,603 | 2,001,173 | 1,238,434 | 9,098,357 | 732,327 | 6,794,395 | 4,807,068 | 4,377,759 | 3,456,000 | 2,913,799 | 1,476,042 | 2,330,399 | 194,200 | 1,685,467 | 917,650 | 14,889,904 |
Flusso di cassa
| Metrica | Tendenza | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $288.2K | $290.4K | $327.4K | $257.9K | $243.9K | $237.5K | $369.1K | $241.6K | $227.8K | $267.5K | $231.4K | $247.6K | $112.0K | $353.0K | $398.2K | · | |
| Stock-based Comp | $97.4K | $24.2K | $61.6K | $12.0K | $12.0K | $12.0K | $12.0K | $202.0K | $12.2K | $218.3K | · | · | $0 | $0 | $260.0K | · | |
| Amort. of Intangibles | $482.3K | $215.6K | $212.2K | $242.4K | $234.1K | $238.9K | $240.8K | $235.5K | $221.3K | $255.5K | $227.5K | $243.2K | $119.2K | $346.5K | $340.0K | $0 | |
| Other Non-cash | · | · | · | $-133.7K | · | · | · | $-145.2K | · | · | · | $865.8K | · | · | · | · | |
| Operating Cash Flow | $-3M | $-4M | $-2M | $-3M | $-2M | $-3M | $-2M | $-2M | $-3M | $-2M | $-3M | $-1M | $-584.3K | $-3M | $-2M | $-2M | |
| CapEx | $0 | $-12.9K | $68.2K | $70.4K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Investing Cash Flow | $0 | $12.9K | $-28.1K | $-70.4K | $-208.5K | $-14.4K | · | · | $-167.3K | $2.6K | · | · | $-181.8K | $173.8K | $-211.3K | $-474.9K | |
| Stock Issued | · | · | · | · | · | $809.7K | $676.6K | $34.5K | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $809.7K | $676.6K | $34.5K | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $312.0K | $10M | $674.7K | $4M | $602.0K | $3M | $631.7K | $42.5K | $5.3K | $11M | · | · | $46.1K | $2M | · | · | |
| Net Change in Cash | $-3M | $6M | $-919.7K | $640.2K | $-2M | $564.9K | $-2M | $-2M | $-3M | $8M | $932.6K | $-1M | $-743.3K | $-631.1K | $-3M | $-2M | |
| Free Cash Flow | · | · | · | $-3M | · | · | · | · | · | · | · | · | · | · | · | · |
Redditività
| Metrica | Tendenza | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 50.5% | 51.3% | 46.6% | · | 37.8% | 30.1% | 34.7% | · | 21.7% | 26.1% | 29.2% | · | 7.2% | 68.4% | · | |
| Operating Margin | · | -277.8% | -293.9% | -269.8% | · | -283.0% | -305.5% | -273.0% | · | -358.6% | -260.6% | -317.4% | · | -1431.6% | -597.5% | -391.4% | |
| Net Margin | · | -269.9% | -298.6% | -268.3% | · | -281.9% | -303.5% | -269.0% | · | -361.5% | -257.8% | -304.6% | · | -1388.0% | -117.9% | -388.1% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | -1389.8% | · | · | |
| EBITDA Margin | · | -277.8% | -293.9% | -246.6% | · | -283.0% | -305.5% | -248.8% | · | -358.6% | -260.6% | -286.2% | · | -1431.6% | -597.5% | -391.4% | |
| ROA | · | -23.4% | -20.3% | -27.4% | · | -19.1% | -25.7% | -26.3% | · | -21.5% | -14.7% | -25.7% | · | -50.7% | -2.5% | -8.3% | |
| ROE | · | -40.7% | -34.6% | -61.3% | · | -31.3% | -58.8% | -72.0% | · | -34.7% | -28.9% | -73.1% | · | -85.7% | -4.1% | -12.8% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.1 | 2.4 | 0.9 | · | 1.1 | 0.9 | 1.1 | · | 2.0 | 0.6 | 0.4 | · | 1.3 | 1.3 | 3.5 | |
| Quick Ratio | · | 1.7 | 0.2 | 0.5 | · | 0.7 | 0.6 | 0.8 | · | 1.7 | 0.3 | 0.1 | · | 0.7 | 0.7 | 2.4 | |
| Debt / Equity | · | · | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.1 | 0.3 | · | 0.1 | 0.0 | · |
Efficienza
| Metrica | Tendenza | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | · | 0.8 | 0.7 | 0.9 | · | 0.5 | 0.5 | 0.6 | · | 0.8 | 0.7 | 1.2 | · | 1.2 | 0.3 | · | |
| Receivables Turnover | · | 1.5 | 2.5 | 1.7 | · | 1.9 | 2.8 | 1.7 | · | 2.3 | 2.8 | 2.8 | · | 3.1 | 2.6 | · |
Per Azione
| Metrica | Tendenza | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $4.48 | $8.96 | $0.40 | · | $0.75 | $0.91 | $1.39 | · | $3.82 | $2.22 | $0.58 | · | $3.58 | $11.28 | $0.35 | |
| Revenue / Share | · | $0.67 | $0.94 | $0.13 | · | $0.16 | $0.16 | $0.26 | · | $0.40 | $0.80 | $0.34 | · | · | · | · | |
| Cash Flow / Share | · | · | · | $-0.33 | · | · | · | $-0.63 | · | · | · | $-0.56 | · | · | · | · | |
| Cash / Share | · | $3.43 | $0.60 | $0.18 | · | $0.41 | $0.47 | $0.91 | · | $3.23 | $0.76 | $0.08 | · | $1.35 | $3.17 | $0.39 | |
| EPS (TTM) | · | $-14.94 | $-17.55 | $-19.69 | · | $-0.47 | $2.51 | $5.40 | · | $-67.13 | $-134.37 | $-137.86 | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $4M | $4M | $3M | · | $3M | $3M | $3M | · | $3M | $2M | $2M | · | · | · | $2M | |
| Net Income TTM | · | $-12M | $-11M | $-11M | · | $-10M | $-11M | $-10M | · | $-10M | $-13M | $-12M | · | $-10M | $-5M | $-8M | |
| Market Cap | · | $7M | $12M | $9M | · | $10M | $7M | $8M | · | $12M | $6M | $29M | · | $59M | $44M | $1.50B | |
| Enterprise Value | · | · | $11M | $8M | · | $7M | $5M | $4M | · | $3M | $5M | $29M | · | $57M | $41M | · | |
| P/E | · | -0.2 | -0.5 | -0.1 | · | -3.1 | 0.6 | 0.3 | · | -0.1 | -0.0 | -0.1 | · | · | · | · | |
| P/S | · | 1.7 | 3.3 | 2.8 | · | 3.8 | 2.4 | 2.5 | · | 4.3 | 2.5 | 15.6 | · | · | · | 757.8 | |
| P/B | · | 0.7 | 1.1 | 2.6 | · | 1.9 | 1.5 | 1.2 | · | 1.1 | 1.8 | 21.2 | · | 9.7 | 4.3 | 284.2 | |
| P / Tangible Book | · | 1.1 | 1.5 | 62.7 | · | 7.5 | 14.5 | 4.4 | · | 1.9 | · | · | · | 80.2 | 58.6 | 284.2 | |
| P / Cash Flow | · | · | · | -3.3 | · | · | · | -3.2 | · | · | · | -22.0 | · | · | · | -792.6 | |
| EV / Revenue | · | · | 3.1 | 2.4 | · | 2.8 | 1.8 | 1.3 | · | 1.1 | 2.2 | 15.6 | · | · | · | · | |
| Earnings Yield | · | -446.6% | -184.2% | -1930.4% | · | -32.6% | 179.3% | 312.1% | · | -1590.8% | -3312.9% | -1115.4% | · | · | · | · |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Ricavi | $4M | $3M | $3M | $1M | · |
| Margine Lordo % | 48.6% | 40.8% | · | 26.0% | · |
| Margine Operativo % | -299.1% | -348.7% | · | -1002.1% | · |
| Utile netto | $-12M | $-11M | $-10M | $-11M | $-8M |
| EPS Diluito | $-8.44 | $-20.04 | $-6.38 | $-127.00 | $-11.33 |
| Metrica | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | · | 0.1 | · | 0.1 | · |
| Rapporto corrente | 1.4 | 0.8 | · | 0.7 | · |
| Quick Ratio | 1.0 | 0.3 | · | 0.3 | · |
| Metrica | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-12M | $-10M | · | · | · |
Proprietari istituzionali (13F) 8 filer · $416K totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
8
Valore detenuto
$416K
Nuove posizioni
1
Posizioni chiuse
2
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 1 (-5 vs trimestre precedente) | 2 (-2 vs trimestre precedente) | 3 (+3 vs trimestre precedente) | 1 (-1 vs trimestre precedente) | -27K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $324.506 | 141.397 | 77,96% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $47.827 | 20.840 | 11,49% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $13.334 | 5.810 | 3,20% | Azioni |
| UBS Group AG | $13.162 | 5.735 | 3,16% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $9.084 | 3.958 | 2,18% | Azioni |
| Tower Research Capital LLC (TRC) | $7.528 | 3.280 | 1,81% | Azioni |
| OSAIC HOLDINGS, INC. | $460 | 200 | 0,11% | Azioni |
| BARCLAYS PLC | $326 | 142 | 0,08% | Azioni |
Attivisti e proprietari del 5%+ 1 partecipazione
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Gary W. Rollins, The Gary W. Rollins Foundation, The Ma-Ran Foundation | 01 Giugno 2023 | · | Deposito iniziale | M&A / vendita | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 12 insider · 2 dirigenti · 9 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Harry Simeonidis | Chief Executive Officer | 18 Marzo 2026 A | 34.540 | 0 | 0 | $0 |
| Spiro Kevin Sakiris | Chief Financial Officer | 18 Marzo 2026 A | 33.981 | 0 | 0 | $0 |
| Nicola Marion Fraser | Direttore | 18 Marzo 2026 A | 5.000 | 0 | 0 | $0 |
| Jason Isenberg | Direttore | 18 Marzo 2026 A | 5.000 | 0 | 0 | $0 |
| Jonathan Scott Hurd | Direttore | 18 Marzo 2026 A | 5.006 | 0 | 0 | $0 |
| Steven Constantine Boyages | Direttore | 18 Marzo 2026 A | 5.031 | 0 | 0 | $0 |
| Christopher Towers | Direttore | 04 Ottobre 2023 P | 9.880 | 0 | 0 | $0 |
| George Margelis | Direttore | 10 Ottobre 2022 A | 15.000 | 0 | 0 | $0 |
| Lawrence B Fisher | Direttore | 10 Ottobre 2022 A | 15.000 | 0 | 0 | $0 |
| Tom Parmakellis | Direttore | 30 Dicembre 2021 P | 9.300 | 0 | 0 | $0 |
| Victoria Gavrilenko | Direttore | 02 Marzo 2021 P | 37 | 0 | 0 | $0 |
| Life Science Biosensor Diagnostics Pty Ltd | · | 17 Febbraio 2022 S | 1.081.804 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduto da 1 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 5.810 SH | 19 Agosto 2026 | Giornaliero |
INBS Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 7 analisti
COMPRA
Target mediano
$12.00
+622,9%
3 42,9%
Acquisto forte
3 42,9%
Compra
1 14,3%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
1 analisti · 2026-10-04Target medio $12.00 +622,9%
Basso$12.00
Media$12.00
Alto$12.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| INBS | $7M | -0.3 | 38.1% | -294.9% | -292.2% | 48.6% |
| NDRA | $5M | -0.5 | · | · | -376.5% | · |
| CODX | $11M | -0.1 | -84.1% | -7533.6% | -151.8% | 64.3% |
| AMIX | · | · | · | · | · | · |
| NVNO | $210.6K | -0.0 | · | · | -64.7% | · |
| NXL | $11M | -1.1 | 78.8% | -2725.8% | -169.3% | 79.7% |
| TNON | · | · | · | · | · | · |
| IVF | · | -0.0 | 4.7% | · | · | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-K depositato Ago 19, 2026